Adequate relief in a treatment trial with IBS patients: a prospective assessment (Q37253528)

19 August 2017

Adequate relief in a treatment trial with IBS patients: a prospective assessment (English)

1 reference

19 August 2017

4

Ted J Kaptchuk

1 reference

19 August 2017

Maria C F Passos

1

1 reference

19 August 2017

Anthony J Lembo

2

1 reference

19 August 2017

Lisa A Conboy

3

1 reference

19 August 2017

John M Kelly

5

1 reference

19 August 2017

Mary T Quilty

6

1 reference

19 August 2017

Catherine E Kerr

7

1 reference

19 August 2017

Eric E Jacobson

8

1 reference

19 August 2017

Rong Hu

9

1 reference

19 August 2017

Elizabeth Friedlander

10

1 reference

19 August 2017

Douglas A Drossman

11

1 reference

19 August 2017

language of work or name

English

0 references

publication date

17 March 2009

1 reference

The American Journal of Gastroenterology

19 August 2017

1 reference

19 August 2017

104

1 reference

19 August 2017

4

1 reference

19 August 2017

912-919

1 reference

19 August 2017

Irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Design of treatment trials for functional gastrointestinal disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Functional bowel disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Irritable bowel syndrome: toward an understanding of severity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

An Inventory for Measuring Depression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Adequate relief as an endpoint in clinical trials in irritable bowel syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707022

Irritable bowel syndrome: a management strategy

3 September 2018

1 reference

12 December 2020

Adequate relief in IBS treatment trials: corrections to errors stated by Whitehead et al

1 reference

12 December 2020

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

1 reference

12 December 2020

Quality of life in persons with irritable bowel syndrome: development and validation of a new measure

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2009.13

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19293784

1 reference